Impilo Overview
Impilo is a Nordic investment company specializing in the pharmaceutical, medical technology, healthcare services, and other health-related industries. The firm emphasizes investments that contribute positively to societal development and sustainability. Impilo manages approximately EUR 1 billion in capital from leading Nordic and international investors.
Is Impilo the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Impilo, along with a list of other relevant VCs, is available on Hopohopo.io.
Impilo
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
Product type
- Software
- Hardware
- Services
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Series B or later
First ticket size
€50,000,000 - €200,000,000
Contact information
Investment Manager
Alexander From
Investment Manager
Matilda Hessedahl
Partner
Nicholas Hooge
Senior Investment Manager
Edvard Hubendick
Stud.polit | Investment Analyst
Mads Jepsen
How to approach funds like Impilo
When engaging with Impilo, founders should highlight how their business model drives measurable improvements in patient outcomes, operational efficiency, or access to care. Demonstrate a clear path to scalable impact within the Nordic healthcare ecosystem, and be prepared to discuss regulatory navigation and long-term value creation. Impilo values management teams with deep sector expertise and a track record of executing in complex, regulated environments.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
